Doctor Peter J. Schlegel, MD is an expert in the field of Oncology. He went to medical school at Rush Medical College. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Peter Schlegel is a published doctor. He has 1 paper published. The most current publication "Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma." He accepts Medicare payments and is listed with Medicare.gov.
|
Dr. Hakan Kaya, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Bruce A. Cutter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ying Zhuo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Jay L. Wittenkeller, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arvind Chaudhry, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Irfan Jawed, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Kawal D. Chester, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark E. Sienko, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Corliss L. Newman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Srivalli Gopaluni, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Robert H. Laugen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Joni C. Nichols, MD
This Doctor is OpenDoctor Recommended.
|